B 
388.31
+1.77%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$2.58bn
FY2016FY2025
Net income
$759.9m
FY2016FY2025
Free cash flow
$374.6m
FY2016FY2025
Shareholders' equity
$7.45bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.58bn | $2.57bn | $2.67bn | $2.80bn | $2.92bn | $2.55bn | $2.31bn | $2.29bn | $2.16bn | $2.07bn |
| Gross profit | $1.34bn | $1.38bn | $1.43bn | $1.57bn | $1.64bn | $1.44bn | $1.26bn | $1.22bn | $1.19bn | $1.14bn |
| Research and development | $256.9m | $295.9m | $247.4m | $256.9m | $260.6m | $217.8m | $202.7m | $199.2m | $250.3m | $205.9m |
| Operating income | $270.5m | $269.0m | $337.8m | $482.6m | $501.9m | $443.2m | $229.7m | −$108.6m | $116.0m | $53.2m |
| Net income | $759.9m | −$1.84bn | −$637.3m | −$3.63bn | $4.25bn | $3.81bn | $1.76bn | $361.0m | $114.7m | $28.1m |
| Diluted earnings per share | 28.13 | -65.87 | -22.12 | -121.76 | 142.18 | 126.42 | 58.19 | 12.08 | 3.81 | 0.95 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $10.58bn | $9.36bn | $12.30bn | $13.50bn | $17.80bn | $12.97bn | $8.01bn | $5.61bn | $4.27bn | $3.85bn |
| Cash and short-term investments | $1.54bn | $1.66bn | $1.61bn | $1.79bn | $869.9m | $991.1m | $1.11bn | $844.8m | $755.0m | $839.4m |
| Total liabilities | $3.12bn | $2.79bn | $3.56bn | $3.89bn | $4.11bn | $3.09bn | $2.25bn | $1.59bn | $1.34bn | $1.27bn |
| Debt | $1.24bn | $1.20bn | $1.20bn | $1.20bn | $11.0m | $14.0m | $440.0m | $439.0m | $435.0m | $435.0m |
| Shareholders' equity | $7.45bn | $6.57bn | $8.74bn | $9.62bn | $13.69bn | $9.88bn | $5.76bn | $4.02bn | $2.93bn | $2.58bn |
| Shares outstanding | 27m | 28m | 29m | 30m | 30m | 30m | 30m | 30m | 30m | 30m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $532.2m | $455.2m | $374.9m | $194.4m | $656.5m | $585.0m | $457.9m | $285.5m | $104.1m | $216.1m |
| Capital spending | −$157.6m | −$189.0m | −$156.7m | −$114.2m | −$120.8m | −$108.6m | −$98.5m | −$129.8m | −$115.1m | −$141.6m |
| Free cash flow | $374.6m | $266.2m | $218.3m | $80.3m | $535.7m | $476.4m | $359.4m | $155.7m | −$11.0m | $74.5m |
| Dividends paid | — | — | −$100.10bn | −$68.18bn | −$35.28bn | −$20.2m | −$3.83bn | — | −$4.4m | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $651.0m | $592.1m | $693.2m | $653.0m | $651.6m | $585.4m | $667.5m | $649.7m |
| Gross profit | $345.8m | $309.4m | $345.2m | $343.4m | $345.3m | $306.0m | $341.9m | $355.9m |
| Operating income | $72.6m | $34.1m | $61.9m | $66.4m | $77.1m | $23.7m | $58.3m | $64.5m |
| Net income | $371.4m | −$527.1m | $720.0m | −$341.9m | $317.8m | $64.0m | −$715.8m | $653.2m |
| Diluted earnings per share | 13.85 | -19.66 | 26.65 | -12.66 | 11.77 | 2.37 | -25.57 | 23.33 |
| Cash from operations | $98.0m | $108.0m | $164.0m | $120.0m | $116.0m | $129.0m | $124.0m | $163.0m |
| Capital spending | −$32.0m | −$30.0m | −$45.0m | −$31.0m | −$45.0m | −$34.0m | −$42.0m | −$63.0m |
| Free cash flow | $66.0m | $78.0m | $119.0m | $89.0m | $71.0m | $95.0m | $82.0m | $100.0m |
| Total assets | $10.25bn | $9.79bn | $10.58bn | $9.70bn | $10.21bn | $9.53bn | $9.36bn | $10.60bn |
| Cash and short-term investments | $1.62bn | $1.56bn | $1.54bn | $1.42bn | $1.37bn | $1.66bn | $1.66bn | $1.62bn |
| Debt | $1.20bn | $1.24bn | $1.24bn | $1.24bn | $1.24bn | $1.24bn | $1.24bn | $1.24bn |
| Shareholders' equity | $7.17bn | $6.85bn | $7.45bn | $6.74bn | $7.13bn | $6.68bn | $6.57bn | $7.49bn |
Financial ratios
Data as of 11 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 52.0% | 53.7% | 53.4% | 55.9% | 56.1% | 56.5% |
| Operating margin | 40.4% | -89.4% | -30.0% | -166.5% | 186.5% | 194.1% |
| Net margin | 29.4% | -71.9% | -23.9% | -129.5% | 145.6% | 149.8% |
| Return on equity | 10.2% | -28.1% | -7.3% | -37.7% | 31.1% | 38.6% |
| Return on assets | 7.2% | -19.7% | -5.2% | -26.9% | 23.9% | 29.4% |
| Free cash flow yield | 7.0% | 6.3% | 5.0% | 2.8% | 7.1% | 6.3% |
| Revenue growth | 0.7% | -3.9% | -4.7% | -4.1% | 14.8% | 10.1% |
| Earnings growth | -141.2% | 189.4% | -82.4% | -185.3% | 11.5% | 116.9% |
| Current ratio | 5.62x | 6.48x | 5.83x | 5.55x | 2.92x | 3.39x |
| Debt to equity | 0.17x | 0.19x | 0.14x | 0.13x | 0.00x | 0.01x |
| Equity ratio | 70.5% | 70.2% | 71.1% | 71.2% | 76.9% | 76.2% |
| Interest coverage | 21.32x | -46.90x | -16.20x | -122.43x | 3514.25x | 225.97x |
| R&D as a share of sales | 9.9% | 11.5% | 9.3% | 9.2% | 8.9% | 8.6% |
| Buybacks as a share of market value | 3.5% | 2.8% | 3.3% | 0.4% | 0.8% | 0.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -2.7% | 0.3% | 2.5% |
| Operating income | -17.6% | -9.4% | 5.0% |
| Net income | — | -27.6% | 21.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 52.9% | 53.8% | 54.6% | 54.6% |
| Operating margin | 10.5% | 12.8% | 14.3% | 10.3% |
| Net margin | -21.1% | -50.4% | 16.9% | 18.9% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 10.8 | -5.0 | -14.6 | -3.5 | 5.3 | 4.6 | 6.4 | 19.2 | 62.6 | 191.5 |
| Price to sales | 3.2 | 3.6 | 3.5 | 4.5 | 7.7 | 6.9 | 4.8 | 3.0 | 3.3 | 2.6 |
Market value over time
30 Nov 2016 to 9 Oct 2026, in USD
$5.21bn$9.82bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -7% | 3% | -22% | -45% | 23% | 59% | 61% | -6% | 36% | 32% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.